Back to Journals » OncoTargets and Therapy » Volume 10

ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma

Total article views   HTML views PDF downloads Totals
16,565 Dovepress* 10,124+ 1,533 11,657
PubMed Central* 6,441 759 7,200
Totals 16,565 2,292 18,857
*Since 11 July 2017
Total mentioned Facebook Delicious Reddit Twitter Others
11 1 0 0 4 6

View citations on PubMed Central and Google Scholar